Storage and handling
Other information Protect the product in this container from excessive heat and direct sun
No7 Lift and Luminate Day Sunscreen Broad Spectrum SPF 15
- Manufacturer
- BCM Ltd | The Boots Company PLC
- Effective date
- 2012-05-01
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 22:31:39
Label at a glance#
ProductNo7 Lift and Luminate Day Sunscreen Broad Spectrum SPF 15
Active ingredientAvobenzone, Octinoxate, Octocrylene
Label structure18 sections
Contacts and useful links#
Websitewww.boots.com
www.Boots.com/no7
www.Boots.com/no7Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active Ingredients Avobenzone 3%, Octinoxate 5%, Octocrylene 1%
Purpose Sunscreen
OTC - PURPOSE SECTION
Uses helps prevent sunburn
WARNINGS AND PRECAUTIONS SECTION
Warnings
For external use only
Do not use on damaged or broken skin
When using this product keep out if eyes. Rinse with water to remove.
OTC - ASK DOCTOR SECTION
Stop use and ask a doctor if rash occurs.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. If swallowed get medical help or contact a poison control center right away.
INDICATIONS & USAGE SECTION
Directons
Apply liberally 15 minutes before sun exposure
Use a water resistant sunscreen if swimming or sweating
Reapply at least every 2 hours
Chidren under 6 months of age: Ask a doctor
Sun Protection Measures
Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a broad spectrum SPF value of 15 or higher and other sun protection measures including:
limit time in the sun, especially from 10a,m - 2p.m
wear long-sleeved shirts, pants, hat and sunglasses
STORAGE AND HANDLING SECTION
Other information
Protect the product in this container from excessive heat and direct sun
INACTIVE INGREDIENT SECTION
Inactive Ingredients
Aqua (water), Glycerin, C12-15 alkyl benzoate, Butyrospermum parkii (shea) butter, Butylene glycol, Cetearyl glucoside, C18-36 acid glycol ester, Dimethicone, Mica, Cetearyl alcohol, Cyclopentasiloxane, Ammonium acryloyldimethyltaurate/VP coplymer, Phenoxyethanol, Cyclohexasiloxane, Potassium cetyl phosphate, Dipalmitoyl hydroxyproline, Xanthan gum, Methylparaben, Sodium ascorbyl phosphate, Dimethiconol, Parfum (Fragrance), Ethylparaben, Dipropylene glycol, Tetrasodium EDTA, Citric acid, T-butyl alcohol, Lupinus albus seed extract, Carbomer, Polysorbate 20, Haematococcus Pluvialis powder, BHT, Polyglucuronic acid, Potassium sorbate, Simethicone, Butylparaben, Propylparaben, Isobutylparaben, Palmitoyl oligopeptide, Palmitoyl tetrapeptide-7, Biotin, CI 77891 (Titanium dioxide)
OTC - QUESTIONS SECTION
USA: Questions? 1-866-75-BOOTS
DESCRIPTION SECTION
Firm, lift and brighten your skin with this multitasking day cream. Formulated to give your skin an instant brightening boost and healthy glow, it then works day by day to chase away the signs of ageing. Visibly reduces the appearance of lines and wrinkles, evens skin tone and lifts and firms for younger more luminous looking skin in 4 weeks.
INFORMATION FOR PATIENTS SECTION
Hypoallergenic
The Boots company PLC Nottingham England NG2 3AA
Dist. by Boots Retail USA Inc. Norwalk CT 06851 USA
Made in the UKwww.Boots.com/no7
INSTRUCTIONS FOR USE SECTION
For Best Results: After cleansing, massage in small upward circles over your face and neck
Our unique anti-ageing and energising complexes containing an effective fusion of pepides, lipoamino acid and Vitamin C work to smooth and firm your skin and restore natural radiance.
Our unique anti-ageing and energising complexes containing an effective fusion of pepides, lipoamino acid and Vitamin C work to smooth and firm your skin and restore natural radiance.
OTC - ACTIVE INGREDIENT SECTION
JAR TEXT
Active ingredients: Octinoxate 6%, Avobenzone 3%, Octocrylene 1%
WARNINGS SECTION
JAR TEXT
Warning: Avoid contact with eyes. If product gets into the eyes rinse well with water immediately.
INDICATIONS & USAGE SECTION
JAR TEXT
Smooth into your face and neck after applying your No7 serum.
INFORMATION FOR PATIENTS SECTION
JAR TEXT
The Boots Company PLC Nottingham England NG2 3AA
Dist. in the USA by Boots Retail USA Inc. Norwalk CT 06851 USA
Made in the UKwww.Boots.com/no7
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
No7 Lift and Luminate
Day Cream
Visibly lifts and improves the appearance of deep lines in 4 weeks
Sunscreen broad spectrum SPF 15
50ml 1.6US Fl.Oz
No7 LL Day Cream SPF 15 carton.jpg
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
JAR TEXT
No7 Protect and Perfect Day Cream
Hypo-allergenic
Sunscreen Broad Spectrum SPF 15
50ml 1.6 US Fl.Oz
No7 LL Day Cream SPF 15 jar.jpg
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 11489-075-01 | 2019-11-13 | C162847 | 48780-1 | 97449f38-b63f-f6ea-e053-dbdaa90aa703 | Carton and jar labelling |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 11489-075-01 | No7 Lift and Luminate Day Sunscreen Broad Spectrum SPF 15 | 50 mL in 1 JAR | CREAM | 50 | 1 | |
| 11489-075-01 | No7 Lift and Luminate Day Sunscreen Broad Spectrum SPF 15 | 1 in 1 CARTON | CREAM | 1 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Avobenzone | ACTIVE INGREDIENT | G63QQF2NOX | 1 | |
| Octinoxate | ACTIVE INGREDIENT | 4Y5P7MUD51 | 1 | |
| Octocrylene | ACTIVE INGREDIENT | 5A68WGF6WM | 1 | |
| Avobenzone | ACTIVE MOIETY | G63QQF2NOX | 1 | |
| Octinoxate | ACTIVE MOIETY | 4Y5P7MUD51 | 1 | |
| Octocrylene | ACTIVE MOIETY | 5A68WGF6WM | 1 | |
| ALKYL (C12-15) BENZOATE | INACTIVE INGREDIENT | A9EJ3J61HQ | 1 | |
| AMMONIUM ACRYLOYLDIMETHYLTAURATE/VP COPOLYMER | INACTIVE INGREDIENT | W59H9296ZG | 1 | |
| biotin | INACTIVE INGREDIENT | 6SO6U10H04 | 1 | |
| BUTYLATED HYDROXYTOLUENE | INACTIVE INGREDIENT | 1P9D0Z171K | 1 | |
| BUTYLENE GLYCOL | INACTIVE INGREDIENT | 3XUS85K0RA | 1 | |
| BUTYLPARABEN | INACTIVE INGREDIENT | 3QPI1U3FV8 | 1 | |
| CETEARYL GLUCOSIDE | INACTIVE INGREDIENT | 09FUA47KNA | 1 | |
| CETOSTEARYL ALCOHOL | INACTIVE INGREDIENT | 2DMT128M1S | 1 | |
| CITRIC ACID MONOHYDRATE | INACTIVE INGREDIENT | 2968PHW8QP | 1 | |
| CYCLOMETHICONE 5 | INACTIVE INGREDIENT | 0THT5PCI0R | 1 | |
| CYCLOMETHICONE 6 | INACTIVE INGREDIENT | XHK3U310BA | 1 | |
| Dimethicone | INACTIVE INGREDIENT | 92RU3N3Y1O | 1 | |
| DIPALMITOYL HYDROXYPROLINE | INACTIVE INGREDIENT | E6AHA53N1H | 1 | |
| DIPROPYLENE GLYCOL | INACTIVE INGREDIENT | E107L85C40 | 1 | |
| EDETATE SODIUM | INACTIVE INGREDIENT | MP1J8420LU | 1 | |
| ETHYLPARABEN | INACTIVE INGREDIENT | 14255EXE39 | 1 | |
| Glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| HAEMATOCOCCUS PLUVIALIS | INACTIVE INGREDIENT | 31T0FF0472 | 1 | |
| ISOBUTYLPARABEN | INACTIVE INGREDIENT | 0QQJ25X58G | 1 | |
| LUPINUS ALBUS SEED | INACTIVE INGREDIENT | 24GB753W3B | 1 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | 1 | |
| mica | INACTIVE INGREDIENT | V8A1AW0880 | 1 | |
| PALMITOYL OLIGOPEPTIDE | INACTIVE INGREDIENT | HO4ZT5S86C | 1 | |
| PALMITOYL TETRAPEPTIDE-7 | INACTIVE INGREDIENT | Q41S464P1R | 1 | |
| Phenoxyethanol | INACTIVE INGREDIENT | HIE492ZZ3T | 1 | |
| POLYSORBATE 20 | INACTIVE INGREDIENT | 7T1F30V5YH | 1 | |
| POTASSIUM CETYL PHOSPHATE | INACTIVE INGREDIENT | 03KCY6P7UT | 1 | |
| POTASSIUM SORBATE | INACTIVE INGREDIENT | 1VPU26JZZ4 | 1 | |
| PROPYLPARABEN | INACTIVE INGREDIENT | Z8IX2SC1OH | 1 | |
| SHEA BUTTER | INACTIVE INGREDIENT | K49155WL9Y | 1 | |
| SODIUM ASCORBYL PHOSPHATE | INACTIVE INGREDIENT | 836SJG51DR | 1 | |
| TERT-BUTYL ALCOHOL | INACTIVE INGREDIENT | MD83SFE959 | 1 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 1 | |
| XANTHAN GUM | INACTIVE INGREDIENT | TTV12P4NEE | 1 |
Products#
Every source-derived product name is available through these pages.
- No7 Lift and Luminate Day Sunscreen Broad Spectrum SPF 15
- Avobenzone, Octinoxate, Octocrylene
- Avobenzone
- Octinoxate
- Octocrylene
- Water
- Glycerin
- ALKYL (C12-15) BENZOATE
- SHEA BUTTER
- BUTYLENE GLYCOL
- CETEARYL GLUCOSIDE
- Dimethicone
- mica
- CETOSTEARYL ALCOHOL
- CYCLOMETHICONE 5
- AMMONIUM ACRYLOYLDIMETHYLTAURATE/VP COPOLYMER
- Phenoxyethanol
- CYCLOMETHICONE 6
- POTASSIUM CETYL PHOSPHATE
- DIPALMITOYL HYDROXYPROLINE
- XANTHAN GUM
- METHYLPARABEN
- SODIUM ASCORBYL PHOSPHATE
- ETHYLPARABEN
- DIPROPYLENE GLYCOL
- EDETATE SODIUM
- CITRIC ACID MONOHYDRATE
- TERT-BUTYL ALCOHOL
- LUPINUS ALBUS SEED
- POLYSORBATE 20
- HAEMATOCOCCUS PLUVIALIS
- BUTYLATED HYDROXYTOLUENE
- POTASSIUM SORBATE
- BUTYLPARABEN
- PROPYLPARABEN
- ISOBUTYLPARABEN
- PALMITOYL OLIGOPEPTIDE
- PALMITOYL TETRAPEPTIDE-7
- biotin
- TITANIUM DIOXIDE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 11489-075 | 11489-075-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / INTRAVENOUS | 95 mg | ||
| CETOSTEARYL ALCOHOL | CETOSTEARYL ALCOHOL | 2DMT128M1S | LOTION / TOPICAL | 3627 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION / AURICULAR (OTIC) | 0.05 %w/w | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | CREAM / TOPICAL | 108 mg | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | SPRAY, METERED / NASAL | 40 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | DROPS / NASAL | 26 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | POWDER, FOR SUSPENSION / ORAL | 840 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | INJECTION / SUBCUTANEOUS | 2 mg | ||
| DIPROPYLENE GLYCOL | DIPROPYLENE GLYCOL | E107L85C40 | FILM, EXTENDED RELEASE / TRANSDERMAL | 296 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, SOLUTION / INTRAVENOUS | 45 mg | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | GEL, METERED / TOPICAL | 4 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | MOUTHWASH / BUCCAL | 100 mg/1ml | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | FILM, EXTENDED RELEASE / TRANSDERMAL | NA | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | AEROSOL, FOAM / VAGINAL | 3 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / SOFT TISSUE | 0.15 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION, EXTENDED RELEASE / ORAL | 2000 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOAP / TOPICAL | 0.5 %w/w | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | SUSPENSION/ DROPS / OPHTHALMIC | 0.01 %w/w | ||
| BUTYLPARABEN | BUTYLPARABEN | 3QPI1U3FV8 | DROPS / ORAL | NA | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | CREAM, AUGMENTED / TOPICAL | 10 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CREAM / VAGINAL | 60 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION/ DROPS / TOPICAL | 0.01 %w/v | ||
| CETOSTEARYL ALCOHOL | CETOSTEARYL ALCOHOL | 2DMT128M1S | CREAM / VAGINAL | 6 mg | ||
| ETHYLPARABEN | ETHYLPARABEN | 14255EXE39 | POWDER, FOR SOLUTION / ORAL | 13 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SYSTEM / TOPICAL | 0.2 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | GRANULE, FOR SUSPENSION / ORAL | 80 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, SOLUTION / EPIDURAL | 30 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | 3.6 mg | ||
| CETOSTEARYL ALCOHOL | CETOSTEARYL ALCOHOL | 2DMT128M1S | OINTMENT / TOPICAL | 1.2 %w/w | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | SUSPENSION / RECTAL | 452 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | CREAM / VAGINAL | 0.49 %w/w | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | CAPSULE, LIQUID FILLED / ORAL | 0.1 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / BUCCAL | NA | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | SOLUTION, GEL FORMING, EXTENDED RELEASE / OPHTHALMIC | 0.6 %w/w | ||
| CETOSTEARYL ALCOHOL | CETOSTEARYL ALCOHOL | 2DMT128M1S | TABLET, EXTENDED RELEASE / ORAL | 800 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | NA | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | SUPPOSITORY / VAGINAL | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, EXTENDED RELEASE / ORAL | 45 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / AURICULAR (OTIC) | 63.64 %w/v | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | PASTE, DENTIFRICE / DENTAL | 0.4 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | LIQUID / ORAL | 162 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | SUSPENSION / ORAL | 360 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | POWDER / ORAL | NA | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | LIQUID / TOPICAL | 2.5 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION/ DROPS / OPHTHALMIC | 0.05 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / ORAL | 32400 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION, SOLUTION / PARENTERAL | 30 mg | ||
| EDETATE SODIUM | EDETATE SODIUM | MP1J8420LU | SPONGE / TOPICAL | 0.14 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION, CONCENTRATE / ORAL | 200 mg/1ml | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | PASTE / DENTAL | 20 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SOLUTION/ DROPS / OPHTHALMIC | 0.05 %w/v | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | CREAM / TOPICAL | 80 mg | ||
| POLYSORBATE 20 | POLYSORBATE 20 | 7T1F30V5YH | INJECTION, SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 60 mg | ||
| PROPYLPARABEN | PROPYLPARABEN | Z8IX2SC1OH | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 0.8 mg | ||
| BUTYLATED HYDROXYTOLUENE | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | OINTMENT / TOPICAL | 57 mg | ||
| TITANIUM DIOXIDE | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, DELAYED RELEASE PELLETS / ORAL | 24 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / INTRAOCULAR | 1 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | OINTMENT / TOPICAL | NA | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SUSPENSION / AURICULAR (OTIC) | NA | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SHAMPOO, SUSPENSION / TOPICAL | 0.15 %w/w |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 45a761e9-5754-4011-b8c3-4f31fe74614c | 318fd7e0-dac5-4c7b-a9c9-7945895fb506 | 2012-05-01 | Warnings | 45a761e9-5754-4011-b8c3-4f31fe74614c 318fd7e0-dac5-4c7b-a9c9-7945895fb506 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.